The drugmaker wants a judgment in favor of programs that would let it help cover Medicare patients’ copays for an expensive cardiovascular drug.
Restoring the nation’s production prowess will be a long, hard slog. But it can be done, if companies, politicians, and investors get behind the effort.
Plus, the founder of Whole Foods on pandemic shortages and obesity. And Jack eyes Airbnb's IPO.
Wall Street’s attractions for foreign investors might offset pressure from big jump in America’s budget and trade deficits.
“The thing we like about tech stocks is that we see a lot of runway for them to grow the dividends, first and foremost,” says Mike Barclay, co-manager of the $24 billion Columbia Dividend Income fund.
Gold prices face headwinds with a stronger dollar and economic data pointing to a recovery
Jason Wild’s JW Asset Management made prescient bets on specialty pharma and cannabis companies. What he likes now
Alibaba, given its broad scope, could act in the role once occupied by fixed income when it was an effective offset to equity weakness
The diagnostic giant is now processing 200,000 tests a day for the coronavirus. But with a number of new tests and a business running clinical trials, LabCorp is preparing for whatever normal will be. Plus: the president’s Covid-19 drugs
A focus on value and ESG factors has helped the $6 billion Pioneer fund outperform most of its category peers, returning more than 15% on average annually for the past five years.
In September, ThyssenKrupp sold its elevator division, and is seeking consolidation in its steel business and shipbuilding arm.
Shares of the maker of battery-powered commercial vehicles jumped almost 13% Friday. The market is prepping for a decision from the U.S. Postal Service about a potential order for Workhorse vehicles.
The Providence, R.I.–based university used sizable allocations of private equity and absolute-return strategies to return 12.1%, ahead of Harvard and Yale, with their massive endowments. Performance is vital in a year when universities are losing money.
The semiconductor supplier reported stronger demand, especially for chips used in autos and mobile devices. The business environment is improving faster than expected, according to CEO Kurt Sievers.
New Street Research analyst Pierre Ferragu set a one-year price target of $400 that would imply a loss of more than a quarter of the chip maker’s valuation.
Seventeen companies went public as of late September. For patient stockpickers, that could offer entry into innovative stars.
R. Ted Weschler, one of Warren Buffett’s lieutenants, disclosed a large position in embattled retailer Dillard’s. It isn’t a Berkshire Hathaway investment.
About three-fourths of S&P 500 companies beat earnings forecasts during the past four quarters. Some 85% beat during the second quarter, and they did it by 20%, far more than usual.
Download data from an app tracking firm indicates strong subscriber growth.
The launch of four 5G-capable iPhones raises a host of questions, from whether the debut of the iPhone 12s will kick off a supercycle to whether the new phones will really transform the consumer experience.